Solara Active Pharma Sciences Ltd
Solara Active Pharma Sciences Ltd Share Price Today: Live Updates & Key Insights
Get insights on Solara Active Pharma Sciences Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Solara Active Pharma Sciences Ltd Share Price Chart
SOLARA at 10 Jul 2026 06:17 PM Pharmaceuticals
568.90 +2.05(+0.36%)
Lowest Today 546.30
Highest Today 601.00
Today's Open 566.15
Prev. Close 566.85
52 Week High 734.40
52 Week Low 422.00
Solara Active Pharma Sciences Ltd Fundamentals
Traded Volume: 8,38,612
Market Cap(Cr): 2,718.44
Avg Traded Price 575.36
1 Year return -9.43%
Upper Circuit 601
Lower Circuit 546.3
P/E TTM -369.00
P/B Ratio 2.014
Traded Value(Cr) 4770.86
EPS TTM -1.542
Book value/Share 281.480
Dividend Yield 1Y 0.00%
Solara Active Pharma Sciences Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Solara Active Pharma Sciences Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Solara Active Pharma Sciences Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -0.53%
1M -1.91%
3M +18.19%
1Y -9.43%
YTD +0.67%
Solara Active Pharma Sciences Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Solara Active Pharma Sciences Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 3.57L
Day Before Yesterday 3.77L
1W Avg 2.27L
1M Avg 2.67L
3M Avg 2.90L
Solara Active Pharma Sciences Ltd Technical Details
Solara Active Pharma Sciences Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 543
Support 2 517
Support 3 488
Pivot Point : 572
Resistance 1 598
Resistance 2 627
Resistance 3 653
Solara Active Pharma Sciences Ltd Corporate Actions
Solara Active Pharma Sciences Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Solara Active Pharma Sciences Ltd’s capital allocation strategies.
All
Ex-Date 15-May-2024 Type R Description /share@1:3% Record Date 15-May-2024 Ratio 1:3
Ex-Date 18-Aug-2021 Type D Description 3.00/share@30.00% Record Date 20-Aug-2021 Ratio 30.00
Ex-Date 19-Nov-2020 Type D Description 4.00/share@40.00% Record Date 20-Nov-2020 Ratio 40.00
Ex-Date 28-Jul-2020 Type D Description 2.00/share@20.00% Record Date - Ratio 20.00
Ex-Date 06-Aug-2019 Type D Description 5.00/share@50.00% Record Date - Ratio 50.00
Dividends
Announcement Date 18-Aug-2021 Ex Dividend Date 18-Aug-2021 Dividend(%) 30
Announcement Date 19-Nov-2020 Ex Dividend Date 19-Nov-2020 Dividend(%) 40
Announcement Date 28-Jul-2020 Ex Dividend Date 28-Jul-2020 Dividend(%) 20
Announcement Date 06-Aug-2019 Ex Dividend Date 06-Aug-2019 Dividend(%) 50
Bonus
No Bonus has been declared by SOLARA
Splits
No Split has been declared by SOLARA
Others
Ex-Rights Date 15-May-2024 Premium(Rs.) 365.00 Ratio 1:3
Solara Active Pharma Sciences Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Solara Active Pharma Sciences Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Solara Active Pharma Sciences Ltd's relative performance and valuation against major competitors.
Stock Name Morepen Laboratories Ltd ₹61.22 (+0.43%) M. Cap (Cr) 33.55 1 Yr Return (%) -3.27% P/E (TTM) 35.36 PB Ratio 2.69
Stock Name Dishman Carbogen Amcis Ltd ₹195.85 (+1.57%) M. Cap (Cr) 30.71 1 Yr Return (%) -24.57% P/E (TTM) 31.51 PB Ratio 0.46
Stock Name Hikal Ltd ₹244.75 (+4.78%) M. Cap (Cr) 30.18 1 Yr Return (%) -28.61% P/E (TTM) -61.84 PB Ratio 2.52
Stock Name Solara Active Pharma Sciences Ltd ₹568.90 (+0.36%) M. Cap (Cr) 27.18 1 Yr Return (%) -9.43% P/E (TTM) -368.93 PB Ratio 2.18
Stock Name Kwality Pharmaceuticals Ltd ₹2599.50 (-0.95%) M. Cap (Cr) 26.97 1 Yr Return (%) +128.56% P/E (TTM) 39.98 PB Ratio 8.12
Stock Name Sai Parenterals Ltd ₹588.10 (-1.34%) M. Cap (Cr) 25.98 1 Yr Return (%) NaN% P/E (TTM) PB Ratio 5.29
Stock Name Beta Drugs Ltd ₹2366.80 (+8.06%) M. Cap (Cr) 23.99 1 Yr Return (%) +34.17% P/E (TTM) 59.21 PB Ratio 10.03
Solara Active Pharma Sciences Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Solara Active Pharma Sciences Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 152.89 Mar 2025 212.80 Mar 2024 110.95 Mar 2023 156.17 Mar 2022 -241.77
PARTICULARS Investing Activities Mar 2026 -50.14 Mar 2025 -36.83 Mar 2024 -4.66 Mar 2023 -81.13 Mar 2022 -243.08
PARTICULARS Financing Activities Mar 2026 -102.56 Mar 2025 -180.48 Mar 2024 -106.52 Mar 2023 -112.76 Mar 2022 333.59
PARTICULARS Net Cash Flow Mar 2026 0.19 Mar 2025 -4.51 Mar 2024 -0.23 Mar 2023 -37.72 Mar 2022 -151.26
Solara Active Pharma Sciences Ltd Shareholding Pattern
This shows the ownership breakdown of Solara Active Pharma Sciences Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 42.0%
Public 42.89%
Other Institutions 2.61%
FII 11.34%
Mutual Funds 1.16%
About Solara Active Pharma Sciences Ltd
Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs). The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two R&D Centres in Chennai and Bengaluru. The Company offer rich basket of niche high-value products for global markets. The Company has developed 80+ commercial APIs predominantly in anthelmintic, anti-malarias, anti-infective, neuromuscular insomnia and anti-psychotic hyperkalemia segments, among others. These drugs primarily deal with anthelmintic, anti-malarias, beta blockers, muscle relaxants, novel oral anticoagulants, anti-infective and other niche segments.The Company's manufacturing facilities enjoy regulatory approvals from the United States Food and Drug Administration (USFDA); European Directorate for the Quality of Medicines (EDQM); Korea Food & Drug Administration (KFDA) - South Korea; Euro Zone - Good Manufacturing Practice (EUGMP) - Danish, World Health Organization (WHO) - Geneva; Medicines and Healthcare products Regulatory Agency (MHRA); Federal Commission for the Protection against Sanitary Risk (Cofepris) - Mexico; Therapeutic Goods Administration (TGA) - Australia; Pharmaceuticals and Medical Devices Agency (PMDA) - Japan.The Company acquired 100% of the equity shares of Strides Chemicals Private Limited and made it the wholly owned subsidiary of the Company effective from September 1, 2018. During the year 2018-19, the Company's wholly owned subsidiary Strides Chemicals Private Limited amalgamated with the Company on December 20, 2019 and the merger was given effect in February, 2020. The Company's new Greenfield plant situated at SEZ unit, Plot No.:3B,3C,3D, Part 2 and 2A-1, APIIC APSEZ, Atchutapuram Village, Rambilli Mandal, Visakhapatnam - 531011, Andhra Pradesh, commenced commercial production in 2021.The Company acquired 487000 additional stake in Sequent Penems Private Limited, subsidiary company and subsequently Sequent Pharma became the wholly owned subsidiary of Company effective from April 27, 2021. In 2024, the Company sold its entire shareholding in Sequent Penems Private Limited to Symbio Generrics India Private Limited and Sequent Penems Private Limited ceased to be a subsidiary of the Company with effect from April 25, 2024.The wholly owned entity, Synthix Global Pharma Solutions Limited has got incorporated on April 29, 2025. .
Chairman & Independent Directo
RAJAGOPALAN RAMAKRISHNAN
Registered office 201 Devavrata Sector 17 Vashi, Navi Mumbai, Mumbai, Maharashtra, 400703
FAX :91-22-27892924
Background
Incorporation Year 2017
Face Value ₹10.00
Market Lot 1
FAQs on Solara Active Pharma Sciences Ltd
How to buy Solara Active Pharma Sciences Ltd shares?
To buy Solara Active Pharma Sciences Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Solara Active Pharma Sciences Ltd?
The company has a market capitalization of ₹2,718.44.
What is the PE & PB ratio of Solara Active Pharma Sciences Ltd?
PE is -369 and PB is 2.014.
What is the Solara Active Pharma Sciences Ltd dividend for 2025–26?
For the 2025–26 financial year, Solara Active Pharma Sciences Ltd declared a final dividend of 0.00% per share.